BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11004664)

  • 1. Gene expression of neuronal nitric oxide synthase and adrenomedullin in human neuroblastoma using real-time PCR.
    Dötsch J; Harmjanz A; Christiansen H; Hänze J; Lampert F; Rascher W
    Int J Cancer; 2000 Oct; 88(2):172-5. PubMed ID: 11004664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of neuronal and endothelial nitric oxide synthase and neuropeptide Y in congenital ureteropelvic junction obstruction.
    Knerr I; Dittrich K; Miller J; Kummer W; Rösch W; Weidner W; Rascher W
    Urol Res; 2001 Apr; 29(2):134-40. PubMed ID: 11396731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
    Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
    J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation.
    Dötsch J; Hogen N; Nyúl Z; Hänze J; Knerr I; Kirschbaum M; Rascher W
    Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):163-7. PubMed ID: 11451542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of adrenomedullin, leptin, their receptors and neuropeptide Y in hormone-secreting and non-functioning pituitary adenomas, meningiomas and malignant intracranial tumours in humans.
    Knerr I; Schuster S; Nomikos P; Buchfelder M; Dötsch J; Schoof E; Fahlbusch R; Rascher W
    Neuropathol Appl Neurobiol; 2001 Jun; 27(3):215-22. PubMed ID: 11489141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
    Orlando C; Raggi CC; Bagnoni L; Sestini R; Briganti V; La Cava G; Bernini G; Tonini GP; Pazzagli M; Serio M; Maggi M
    Med Pediatr Oncol; 2001 Jan; 36(1):224-6. PubMed ID: 11464890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.
    Dötsch J; Christiansen H; Hänze J; Lampert F; Rascher W
    Regul Pept; 1998 Sep; 75-76():185-90. PubMed ID: 9802408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation of the expression of adrenomedullin, endothelin-1 and nitric oxide synthases in adipose tissues from childhood to adulthood.
    Knerr I; Schirl C; Horbach T; Stuppy A; Carbon R; Rascher W; Dötsch J
    Int J Obes (Lond); 2005 Mar; 29(3):275-80. PubMed ID: 15672108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
    Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
    Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
    van Wezel EM; Decarolis B; Stutterheim J; Zappeij-Kannegieter L; Berthold F; Schumacher-Kuckelkorn R; Simon T; Fiocco M; van Noesel MM; Caron HN; van der Schoot CE; Hero B; Tytgat GAM
    Eur J Cancer; 2016 Feb; 54():149-158. PubMed ID: 26796600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
    Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis.
    Saur D; Vanderwinden JM; Seidler B; Schmid RM; De Laet MH; Allescher HD
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1662-7. PubMed ID: 14757827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.
    Bordow SB; Norris MD; Haber PS; Marshall GM; Haber M
    J Clin Oncol; 1998 Oct; 16(10):3286-94. PubMed ID: 9779703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system.
    Raggi CC; Bagnoni ML; Tonini GP; Maggi M; Vona G; Pinzani P; Mazzocco K; De Bernardi B; Pazzagli M; Orlando C
    Clin Chem; 1999 Nov; 45(11):1918-24. PubMed ID: 10545060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
    Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
    de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
    Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of insulin receptor-related receptor and insulin-like growth factor 1 receptor correlates with enhanced apoptosis and dedifferentiation in human neuroblastomas.
    Weber A; Huesken C; Bergmann E; Kiess W; Christiansen NM; Christiansen H
    Clin Cancer Res; 2003 Nov; 9(15):5683-92. PubMed ID: 14654552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.
    Zhang J; Zheng Y; Wang Y; Tong H
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year.
    Burchill SA; Lewis IJ; Abrams KR; Riley R; Imeson J; Pearson AD; Pinkerton R; Selby P
    J Clin Oncol; 2001 Mar; 19(6):1795-801. PubMed ID: 11251011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.